Correlation of the treatment sensitivity of patient| derived organoids ...

Correlation of the treatment sensitivity of patient-derived organoids ...

Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): ...

Correlation of the treatment sensitivity of patient-derived organoids ...

A prospective study to generate a living biobank of head and neck squamous cell carcinoma patient-derived organoids and treatment sensitivity of organoids can ...

Correlation of the treatment sensitivity of patient- derived organoids ...

head and neck squamous cell carcinoma patient- derived organoids and treatment sensitivity of or- ganoids can be correlated with clinical ...

881P SOTO study - Annals of Oncology

881P SOTO study: Prospective study to correlate the treatment sensitivity of patient-derived organoids (PDOs) with treatment outcomes in head and neck cancer ...

Correlation of the treatment sensitivity of patient-derived organoids ...

Whether PDOs can be used to predict treatment sensitivity in HNSCC patients as well as to explore potential biomarkers is assessed and PDOs ...

Patient-derived organoids as a predictive biomarker for treatment ...

Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, ...

Organoid Sensitivity Correlates with Therapeutic Response in ...

Drug sensitivity testing on PDOs correlated with clinical responses to treatment in individual patients. Conclusions: These data support the ...

Patient-Derived Cancer Organoids as Predictors of Treatment ...

The TUMOROID study used organoids derived from metastatic CRC and correlated the organoid treatment response towards the corresponding clinical ...

Review Patient-derived organoids in precision cancer medicine

Organoids are three-dimensional (3D) cultures, normally derived from stem cells, that replicate the complex structure and function of human ...

Patient-derived head and neck cancer organoids allow treatment ...

Patient-derived organoids hold promise for personalized medicine, as multiple studies have shown correlation between organoid drug response and ...

Organoids as a biomarker for personalized treatment in metastatic ...

Previous studies involving colorectal cancer (CRC) patients have demonstrated a correlation between organoid response and patient response to ...

The Efficacy of Using Patient-Derived Organoids to Predict ... - MDPI

Here, we review studies that have explored the relationship between ex vivo organoid sensitivity and patient treatment response, to evaluate the role of patient ...

The landscape of drug sensitivity and resistance in sarcoma

Patient-derived tumor organoids (PDTOs) are ideally suited to fill this gap, as they are tractable and predictive of response to treatment, at least for ...

Systematic review: predictive value of organoids in colorectal cancer

It is however not explicitly stated how organoids were classified as drug sensitive or resistant. Narashiman et al. found that the drug ...

Patient-derived organoids model treatment response of metastatic ...

Phenotypic and genotypic profiling of PDOs showed a high degree of similarity to the original patient tumors. Molecular profiling of tumor ...

Patient-derived organoid (PDO) platforms to facilitate clinical ...

... correlation between genetic mutations and sensitivity to targeted therapy. Organoids have also been used in co-clinical trials to compare ...

Correlation between drug sensitivity profiles of circulating tumour ...

CTC-derived organoids were tested for sensitivity to a panel of pancreatic ductal adenocarcinoma treatments. •. Drug sensitivity results ...

Organoids as a biomarker for personalized treatment in metastatic ...

We expanded the screens using the optimized methods for all PDOs. Organoid sensitivity was correlated to the patient's response, determined by % ...

Patient-derived glioblastoma organoids reflect tumor heterogeneity ...

Treatment sensitivity of patient-derived glioblastoma organoids (PGOs): standard-of-care treatment and proof-of-principle targeted therapy.

Patient-derived organoids can predict response to chemotherapy in ...

In a clinical study, the responses of organoids to irinotecan correlated with patients' responses to the drug, suggesting that organoids could ...